Nan Shen

1.6k total citations
30 papers, 1.2k citations indexed

About

Nan Shen is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nan Shen has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 20 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nan Shen's work include Systemic Lupus Erythematosus Research (19 papers), T-cell and B-cell Immunology (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Nan Shen is often cited by papers focused on Systemic Lupus Erythematosus Research (19 papers), T-cell and B-cell Immunology (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Nan Shen collaborates with scholars based in China, United States and South Korea. Nan Shen's co-authors include Betty P. Tsao, S Ye, Shu‐Ling Chen, Shun‐le Chen, Guang‐Ming Han, Shuang Ye, Guangjie Chen, Bing Yan, Kenneth Kalunian and Daniel J. Wallace and has published in prestigious journals such as Journal of Clinical Investigation, Frontiers in Immunology and Journal of Dairy Science.

In The Last Decade

Nan Shen

29 papers receiving 1.2k citations

Peers

Nan Shen

IMMUN

RHEUM

ONCOL

RNMI

Patrícia Costa‐Reis Portugal

Sergey V. Kozyrev Sweden

María‐Eugenia Miranda‐Carús Spain

Grainne Kearns Ireland

Beverly S. Franek United States

Amalia Raptopoulou Greece

Consuelo Anzilotti United Kingdom

Gerrie Stoeken‐Rijsbergen Netherlands

Chieko Kyogoku Japan

Sokratis A. Apostolidis United States

Patrícia Costa‐Reis Portugal

Nan Shen

775 ×0.9

IMMUN

738 ×1.0

RHEUM

340 ×1.3

122 ×0.6

ONCOL

170 ×0.9

RNMI

Citations per year, relative to Nan Shen Nan Shen (= 1×) peers Patrícia Costa‐Reis

Countries citing papers authored by Nan Shen

Since Specialization

Citations

This map shows the geographic impact of Nan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Shen more than expected).

Fields of papers citing papers by Nan Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Shen. The network helps show where Nan Shen may publish in the future.

Co-authorship network of co-authors of Nan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Shen. A scholar is included among the top collaborators of Nan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Shen. Nan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Haiting, Shaoying Yang, Huihua Ding, et al.. (2025). Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosus. Frontiers in Immunology. 16. 1599473–1599473. 2 indexed citations

Shen, Nan, et al.. (2025). The association between resilience and palliative care problems and needs in cancer patients: a cross-sectional study. Supportive Care in Cancer. 33(6). 485–485.

Deng, Jun, Xiaoyue Jiang, Chao Yao, et al.. (2025). PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1⁺CD8⁺ T cells. Theranostics. 15(11). 5029–5044. 1 indexed citations

Wang, Haiting, Yuhong Zhou, Liqin Yu, et al.. (2022). Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study. Lupus Science & Medicine. 9(1). e000725–e000725. 9 indexed citations

Zhang, Xiaosong, et al.. (2018). A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer. Aging. 10(10). 2741–2754. 5 indexed citations

Shen, Nan, et al.. (2017). Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis. Oncotarget. 8(13). 20784–20793. 11 indexed citations

Qin, Hui, Qiang Guo, Nan Shen, et al.. (2014). Chest imaging manifestations in lupus nephritis. Clinical Rheumatology. 33(6). 817–823. 1 indexed citations

Fan, Wei, Dong Liang, Yuanjia Tang, et al.. (2012). Identification of microRNA‐31 as a novel regulator contributing to impaired interleukin‐2 production in T cells from patients with systemic lupus erythematosus. Arthritis & Rheumatism. 64(11). 3715–3725. 88 indexed citations

Zhang, Hao, et al.. (2011). Single-nucleotide polymorphisms and haplotype of CYP2E1gene associated with systemic lupus erythematosus in Chinese population. Arthritis Research & Therapy. 13(1). R11–R11. 10 indexed citations

10.

Zhou, Shu‐Feng, Xiaolan Lu, Swapan K. Nath, et al.. (2011). Gene–gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. Arthritis & Rheumatism. 64(1). 222–231. 68 indexed citations

11.

Fu, Qiong, Jian Zhao, Xiaoxia Qian, et al.. (2010). Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis & Rheumatism. 63(3). 749–754. 108 indexed citations

12.

Yan, Bing, et al.. (2008). Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon‐α–producing antigen‐presenting cells. Arthritis & Rheumatism. 58(3). 801–812. 151 indexed citations

13.

Tang, Jianping, Yueying Gu, Nan Shen, et al.. (2005). [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].. PubMed. 44(2). 106–10. 1 indexed citations

14.

Feng, Xuebing, et al.. (2004). [OAZ gene polymorphism in Chinese patients with systemic lupus erythematosus].. PubMed. 21(5). 430–4. 2 indexed citations

15.

Lu, Liangjing, Shun‐le Chen, Yueying Gu, et al.. (2003). Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cells.. Chinese Medical Journal. 116(3). 350–3. 1 indexed citations

16.

Han, Guang‐Ming, et al.. (2003). Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes and Immunity. 4(3). 177–186. 221 indexed citations

17.

Tsao, Betty P., Rita M. Cantor, Jennifer M. Grossman, et al.. (2002). Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus. Arthritis & Rheumatism. 46(11). 2928–2936. 43 indexed citations

18.

Wu, Hui, Nan Shen, Yueying Gu, et al.. (2002). [Association between Bcl-2 gene polymorphism with systemic lupus erythematosus].. PubMed. 82(7). 467–70. 8 indexed citations

19.

Tsao, Betty P., Rita M. Cantor, Jennifer M. Grossman, et al.. (1999). PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. Journal of Clinical Investigation. 103(8). 1135–1140. 90 indexed citations

20.

Tsao, Betty P., Rita M. Cantor, Kenneth Kalunian, et al.. (1997). Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.. Journal of Clinical Investigation. 99(4). 725–731. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact